…
ARCpoint Inc. provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States. It operates in two segments, ARCpoint Franchise and AFG Services. The company offers viral testing for viruses, such as Flu, Strep, and covid; regulatory compliance testing; ailments testing; preventive care services, including annual health, heart health, thyroid, diabetes, and hormone testing; nutritional testing comprising food allergy/sensitivity and vitamin/nutrient deficiency testing; and specialty health solutions such as TB and titer, pregnancy - related, respiratory/allergy, and blood type testing services, as well as vaccine, vitamin and supplements injections. It also provides drug, alcohol, and on-site mobile testing; paternity and DNA services; STD; and dry eyes testing services. In addition, the company offers employer solutions consisting of DOT solutions, background screening, HR employment solutions, and employee assistance programs. Further, it provides marketing, technology, and training services. The company provides services to individuals, companies, and legal and healthcare professionals. The company was formerly known as RSI International Systems Inc. ARCpoint Inc. was founded in 1998 and is headquartered in Greenville, South Carolina.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Arian Resources Corp. (ARC.V) is a publicly listed junior mineral exploration company; publicly available information about its projects and operating history is limited. Long-term growth may be driven by successful exploration results, resource definition and supportive commodity prices, and the company could appeal to investors seeking leveraged exposure to potential discoveries.
Primary investment risks include the early-stage nature of the business with a high probability of unsuccessful exploration, need for frequent financing and resulting dilution, low market liquidity and sensitivity to commodity and regulatory cycles.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -2.11M | 1.13M | -9.15M | -8.32M | 5.72M |
| Minority interest | -0.01M | 0.01M | 0.28M | 0.28M | 0.01M |
| Net income | -2.12M | 1.36M | -8.66M | -8.04M | 5.73M |
| Selling general administrative | 2.38M | 6.05M | 8.03M | 9.14M | 6.61M |
| Gross profit | 0.51M | 3.40M | 1.79M | 5.91M | 12.91M |
| Reconciled depreciation | 0.47M | 0.58M | 0.72M | 0.28M | 0.11M |
| Operating income | -2.57M | -3.79M | -7.57M | -3.88M | 5.80M |
| Interest expense | 0.64M | 0.83M | 0.74M | 0.71M | 0.19M |
| Tax provision | 0.00M | -0.22M | -0.21M | 0.00M | - |
| Net interest income | -0.64M | -0.83M | -0.74M | -0.71M | -0.19M |
| Total revenue | 0.61M | 5.51M | 6.67M | 10.88M | 19.15M |
| Total operating expenses | 3.18M | 9.29M | 14.24M | 14.76M | 13.35M |
| Cost of revenue | 0.10M | 2.11M | 4.88M | 4.98M | 6.24M |
| Total other income expense net | 1.11M | 5.75M | -0.84M | -3.73M | 0.11M |
| Net income from continuing ops | -2.11M | 1.35M | -8.94M | -8.32M | 5.72M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 3.04M | 3.26M | 6.75M | 15.12M | 14.18M |
| Intangible assets | 0.05M | 0.43M | 0.80M | 1.18M | 0.13M |
| Other current assets | - | - | 0.53M | 0.54M | 0.47M |
| Total liab | 10.84M | 9.82M | 17.14M | 16.51M | 16.99M |
| Total stockholder equity | -7.75M | -6.47M | -10.31M | -1.59M | -2.81M |
| Capital stock | 11.37M | 10.86M | 8.99M | 8.75M | 0.68M |
| Retained earnings | -20.96M | -18.84M | -20.20M | -11.53M | -3.49M |
| Good will | - | 0.00M | 0.00M | 0.44M | - |
| Cash | 0.00M | 0.08M | 0.92M | 6.00M | 4.97M |
| Total current liabilities | 9.39M | 8.56M | 7.31M | 4.96M | 4.43M |
| Net debt | 8.48M | 7.37M | 6.08M | 0.73M | 1.39M |
| Short long term debt | 7.04M | 6.26M | 4.38M | 2.56M | - |
| Total current assets | 0.44M | 0.74M | 2.91M | 9.25M | 10.99M |
| Long term investments | 2.37M | 1.68M | 0.00M | - | - |
| Net receivables | 0.31M | 0.50M | 0.79M | 1.08M | 2.99M |
| Long term debt | 1.44M | 1.18M | 2.62M | 4.17M | 6.35M |
| Inventory | - | 0.00M | 0.06M | 0.16M | 0.31M |
| Accounts payable | 2.02M | 1.85M | 0.90M | 0.42M | 0.70M |
| Non currrent assets other | - | - | 1.98M | 2.56M | 2.05M |
| Non current assets total | 2.60M | 2.51M | 3.84M | 5.87M | 3.19M |
| Capital lease obligations | 0.03M | 0.16M | 0.79M | 1.34M | 0.98M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | 0.05M | -0.33M | 1.73M | -0.77M |
| Net borrowings | 0.31M | - | - | - | - |
| Total cash from financing activities | 0.85M | 1.77M | -0.60M | -0.56M | -1.58M |
| Net income | -2.12M | 1.36M | -8.66M | -8.04M | 5.73M |
| Change in cash | -0.07M | -0.84M | -5.09M | 1.04M | 2.84M |
| Begin period cash flow | 0.08M | 0.92M | 6.00M | 4.97M | 2.13M |
| End period cash flow | 0.00M | 0.08M | 0.92M | 6.00M | 4.97M |
| Total cash from operating activities | -1.28M | -2.59M | -4.20M | -0.13M | 5.19M |
| Issuance of capital stock | 0.54M | 1.76M | 0.00M | 1.58M | 0.00M |
| Depreciation | 0.47M | 0.58M | 0.72M | 0.28M | 0.11M |
| Dividends paid | 0.00M | 0.00M | 0.00M | 1.54M | 1.74M |
| Change to inventory | - | 0.00M | 0.01M | -0.39M | -0.20M |
| Change to account receivables | 0.21M | -0.34M | -0.04M | 2.14M | 0.76M |
| Sale purchase of stock | - | - | 0.00M | -0.15M | -2.65M |
| Capital expenditures | 0.00M | 0.00M | 0.34M | 1.52M | 0.30M |
| Change in working capital | 0.38M | 1.20M | 2.81M | 4.00M | -0.71M |
| Stock based compensation | 0.30M | 0.46M | 0.14M | 0.98M | 0.00M |
| Other non cash items | 0.64M | -0.28M | -0.06M | 2.16M | -0.01M |
| Free cash flow | -1.28M | -2.59M | -4.54M | -1.65M | 4.89M |
Sector: Healthcare Industry: Diagnostics & Research
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ARC Arian Resources Corp. |
- -% |
0.01 | - | - | 2.12 | - | 15.59 | 2.25 |
| AVCR Avricore Health Inc |
- -% |
0.05 | - | - | 3.16 | 5.09 | 3.30 | 41.13 |
| TELO Telo Genomics Corp |
- -% |
0.05 | - | - | - | 8.78 | - | -6.32 |
| MBI-H Med BioGene Inc |
-0.01 25.00% |
0.01 | - | - | - | - | - | -3.03 |
ARCpoint Inc. provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States. It operates in two segments, ARCpoint Franchise and AFG Services. The company offers viral testing for viruses, such as Flu, Strep, and covid; regulatory compliance testing; ailments testing; preventive care services, including annual health, heart health, thyroid, diabetes, and hormone testing; nutritional testing comprising food allergy/sensitivity and vitamin/nutrient deficiency testing; and specialty health solutions such as TB and titer, pregnancy - related, respiratory/allergy, and blood type testing services, as well as vaccine, vitamin and supplements injections. It also provides drug, alcohol, and on-site mobile testing; paternity and DNA services; STD; and dry eyes testing services. In addition, the company offers employer solutions consisting of DOT solutions, background screening, HR employment solutions, and employee assistance programs. Further, it provides marketing, technology, and training services. The company provides services to individuals, companies, and legal and healthcare professionals. The company was formerly known as RSI International Systems Inc. ARCpoint Inc. was founded in 1998 and is headquartered in Greenville, South Carolina.
101 North Main Street, Greenville, SC, United States, 29601
864 436 0018
| Name | Title | Year Born |
|---|---|---|
| Mr. Adam Blaine Ho | Interim CFO, VP & Non Independent Chairman | NA |
| Mr. John Constantine | CEO, President & Non Independent Director | NA |
| Mr. Jason Tong C.A., C.F.A., CPA, CA, CFA | Controller | 1984 |
| Mr. Robert Mann | President of ARCpoint Franchise Group LLC | NA |
| Mr. Jason Tong C.A., C.F.A., CPA | Controller | 1984 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.